John Sampalis
Overview
Explore the profile of John Sampalis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
533
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enright K, Nikolis A, Sampalis J
J Cutan Med Surg
. 2025 Jan;
12034754241311270.
PMID: 39849853
Background: A review of Health Canada's post-market surveillance database has revealed that the reporting of adverse events (AEs) following aesthetic injectable treatments is significantly underreported. To increase reporting, investigators have...
2.
Lynde C, Poulin Y, Tan J, Lomaga M, Loo W, Carbonneau D, et al.
J Drugs Dermatol
. 2022 Oct;
21(10):1091-1097.
PMID: 36219056
Atopic dermatitis is a common skin disorder for which there remains an unmet need for topical pharmacotherapies that are safe and effective. This phase 2 study assessed the efficacy and...
3.
Dust P, Corban J, Sampalis J, Antoniou J, Bergeron S
J Arthroplasty
. 2021 Sep;
37(2):390-397.
PMID: 34538682
Background: The number of total hip arthroplasties performed per year is increasing for reasons not fully explained by a growing and aging population. The purpose of this study was to...
4.
Nikolis A, Enright K, Lazarova D, Sampalis J
Aesthet Surg J Open Forum
. 2021 Apr;
2(1):ojaa005.
PMID: 33791625
Background: Aesthetic physicians have several hundred injectable products to select from. Due to differences in their manufacturing technology, these products display varying biophysical qualities, such as their cohesivity and lift...
5.
Bissonnette F, Minano Masip J, Kadoch I, Librach C, Sampalis J, Yuzpe A
Fertil Steril
. 2020 Dec;
115(4):991-1000.
PMID: 33267959
Objective: To evaluate the safety profile and the number of usable blastocysts on day 5 and on day 6 after treatment with an individualized dosing regimen of a follitropin delta...
6.
Fitzcharles M, Rampakakis E, Sampalis J, Shir Y, Cohen M, Starr M, et al.
ACR Open Rheumatol
. 2020 May;
2(5):286-293.
PMID: 32353211
Objective: Recreational legalization of cannabis may influence the medical use by patients. When only medical access was legally available in Canada, 4.3% of rheumatology patients reported use. With the current...
7.
Leclerc J, Thibault M, Gonella J, Beaudoin C, Sampalis J
Drugs
. 2020 Apr;
80(7):697-710.
PMID: 32279239
Background: Previous systematic reviews (2008; 2016) concluded similarity in outcomes between brand-name and generic drugs in cardiology, but they included ≥ 50% comparative bioavailability studies, not designed or powered to...
8.
Gilbert L, Ramanakumar A, Festa M, Jardon K, Zeng X, Martins C, et al.
J Comp Eff Res
. 2020 Apr;
9(8):537-551.
PMID: 32223298
To describe the direct healthcare costs associated with repeated cytotoxic chemotherapy treatments for recurrent high-grade serous cancer (HGSC) of the ovaries. Retrospective review of 66 women with recurrent stage III/IV...
9.
Leclerc J, Lesage A, Rochette L, Hunh C, Pelletier E, Sampalis J
J Affect Disord
. 2019 Dec;
263:54-59.
PMID: 31818796
Background: The prevalence of mood disorders was estimated at 5.4% according to the latest Canadian survey. It has been suggested to use administrative data and self-reported data to optimize the...
10.
Liberman M, Goudie E, Morse C, Hanna W, Evans N, Yasufuku K, et al.
J Thorac Cardiovasc Surg
. 2019 Nov;
159(1):301-311.
PMID: 31679701
Objectives: The study objectives were to evaluate the immediate, short-, and medium-term efficacy and safety of pulmonary artery branch sealing using an ultrasonic vessel-sealing device in minimally invasive anatomic lung...